학술논문
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
Document Type
Article
Author
Source
In: American Journal of Cardiovascular Drugs . (American Journal of Cardiovascular Drugs, January 2024, 24(1):117-127)
Subject
Language
English
ISSN
1179187X
11753277
11753277